Financial Highlights

(unit: million yen)

Items (IFRS)	FY2020.3	FY2021.3	FY2022.3	FY2023.3
Revenue	135,563	164,776	192,442	292,449
Operating profit	18,010	25,126	26,446	19,263
Profit attributable to owners of parent	9,846	25,725	18,735	10,929
Total assets	229,958	244,803	298,387	287,448
Total equity	69,174	97,903	105,137	106,957
Equity per share attributable to owners of parent（Yen）	1,758.00	1,244.06	1,336.89	1,395.52
Basic earnings per share（Yen）	250.24	326.90	238.11	141.19
Equity attributable to owners of parent ratio（%）	30.1	40.0	35.2	37.2
Cash flows from operating activities	4,572	△33,353	11,103	36,754
Cash flows from investing activities	1,927	△2,800	△7,820	△3,935
Cash flows from financing activities	273	24,422	△6,044	△23,818
Cash and cash equivalents at end of period	22,908	10,023	6,127	17,952
Number of employees（People）	1,574	1,510	1,457	1,467
Shares issued at end of period（Shares）	39,854,344	39,854,344	79,708,688	79,708,688

1 . The business of Fuji Medical Instruments MFG. Co., Ltd. was reclassified as discontinued operations in the fiscal year ended March 31, 2020.
2 . Starting from the fiscal year ended March 31, 2021, the classification for recording interest on borrowing for metal procurement in North American business was changed from "financial expenses" to "cost of sales". The figures in the fiscal year ended March 31, 2020 were also changed for comparison purpose.